Clinical trial

A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

NCT07100119

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-08-05

PhasePHASE1

Study timeline

Study start (actual)2025-08-05Date precision: day

Registry last updated2026-03-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

ALS (Amyotrophic Lateral Sclerosis)unresolved

Interventions

LY4256984DRUG

PlaceboDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

ValenciaSpain1 LeuvenBelgium1 UlmGermany1 UtrechtNetherlands1 LübeckGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07100119 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.